Results of Sunitinib Treatment of Advanced Neuroendocrine Neoplasms: “Real-life” Outcome Data from the German NET-Register

#1201

Introduction: Among modern treatments (Tx) for neuroendocrine neoplasms (NEN) sunitinib (SUN) has impacted Tx of primarily pancreatic NEN (pNEN).

Aim(s): This study provides recent data on routine SUN-Tx from 5 centres of the German NET-Register.

Materials and methods: Multicentric, retrospective analysis of pts. with histologically proven NEN, progression prior to Tx initiation with SUN and with initial diagnosis from 1988-2013; statistical analysis used SPSS 19.0.

Conference: 12th Annual ENETSConcerence (2015)

Presenting Author:

Authors: Bacher M, Maasberg S, Fottner C, Begum N, Quietzsch D,

Keywords: sunitinib, outcome,

To read the full abstract, please log into your ENETS Member account.